17th treatment shown to reduce risk in
March 2021, now with p = 0.00036 from 31 studies, recognized in 45 countries.
Efficacy is variant dependent.
No treatment is 100% effective. Protocols
combine treatments.
5,100+ studies for
112 treatments. c19early.org
|
risk of death, 6.0% lower, RR 0.94, p = 0.16, treatment 943 of 4,839 (19.5%), control 1,029 of 4,946 (20.8%), NNT 76, all patients.
|
risk of mechanical ventilation, 1.0% higher, RR 1.01, p = 0.88, treatment 484 of 4,556 (10.6%), control 488 of 4,642 (10.5%), all patients.
|
risk of death, 21.0% lower, RR 0.79, p = 0.001, treatment 396 of 1,633 (24.2%), control 452 of 1,520 (29.7%), NNT 18, seronegative patients.
|
risk of mechanical ventilation, 13.0% lower, RR 0.87, p = 0.13, treatment 190 of 1,599 (11.9%), control 202 of 1,484 (13.6%), NNT 58, seronegative patients.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |